SCD1 has been regarded as a critical target in the PI3K-Akt-mTOR pathway in drug resistance, which can protect tumor cells from the threat of ferroptosis by promoting monounsaturated fatty acids (MUFA) synthesis [70]. Here, AKT1 is linked to neoplasm.